Skip to main content
Equibles

STATE STREET CORP

Position in GPCR — Structure Therapeutics Inc.

CIK 93751 BOSTON, MA
Back to GPCR Full portfolio

Position in GPCR

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$2,395,238
+$101,834 QoQ
Shares Held
44,629
-6.2% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 190 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GPCR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. GPCR ranks #261 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in GPCR

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,395,238 44,629
2026-03-31 $2,293,404 47,581
2025-12-31 $3,353,979 48,224
2025-09-30 $1,288,476 46,017
2025-06-30 $693,939 33,459
2025-03-31 $185,909 10,740
2024-12-31 $285,492 10,527
2024-09-30 $539,627 12,295
2024-06-30 $380,290 9,684
2024-03-31 $543,936 12,691
2023-12-31 $568,031 13,936
2023-09-30 $729,073 14,460
2023-06-30 $476,392 11,460